Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
addiction, weight loss
Popular weight loss drugs could help with alcohol, opioid addictions: study
A new study suggests weight loss drugs like Ozempic and Mounjaro could provide a promising new treatment for substance use disorders.
Women turn to weight loss drugs in menopause: What to know about the benefits and risks
Losing weight in menopause can help with the severity of other menopause symptoms like hot flashes and night sweats, according to Shepherd. The average age for menopause, when your periods stop permanently, is 52, according to the U.S. Office on Women's Health. Menopause is reached after it has been a full year since your last period.
Weight-Loss Drugs May Help Alcohol and Opioid Addiction
Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.
Weight-loss drugs could reduce risk of overdoses, new study says
A new study suggests that medications like Ozempic could help reduce the risk of overdose and alcohol intoxication in people with substance use disorders.
Drugs Like Ozempic Were Made For Major Weight Loss. But Could You Use It To Lose 10 Pounds?
Many people use semaglutides like Ozempic for weight loss, but can you use it to lose a small amount—say, 10 or 20 pounds? Doctors explain the concerns.
Can weight-loss drugs like Ozempic help fight addiction?
A recent study revealed that weight loss medications like Ozempic and Mounjaro might help individuals battling addiction. The findings, published in the scientific journal Addiction, said that people with alcohol addiction who were prescribed these medications had a 50 per cent lower rate of binge drinking compared to those who were not.
6h
on MSN
People Are Selling Weight-Loss Drugs On Facebook. Doctors Warn They Could Be Fakes—And Buyers Could Face Jail Time
A new report found people selling leftover weight loss drugs, like Ozempic or Mounjaro, on Facebook. Doctors are ...
3h
Novo Nordisk asks US to stop compounding pharmacies from making weight-loss drug copies
Novo Nordisk on Tuesday asked the U.S. Food and Drug Administration to ban compounding pharmacies from making copycat ...
8h
on MSN
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
6h
People Are Selling Leftover Weight-Loss Drugs On Facebook. Buyers Could Be Harmed—Or Face Jail Time
Yep, you can actually be thrown in jail for buying certain weight loss drugs on Facebook (or any other social media platform, ...
13h
US Medicaid programs say cost a key factor for weight-loss drug coverage, survey finds
Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...
NBC New York
1d
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Subscribe here to receive future editions. Yet another study shows that blockbuster GLP-1
drugs
may offer health benefits ...
Healthline
2d
How Ozempic, GLP-1 Weight Loss Drugs Affect the Brain to Curb Substance Misuse
A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like ...
KSL
11h
Medicaid programs say cost a key factor for weight-loss drug coverage, survey finds
Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...
1d
Shady drugmaker used code words to sell knockoff weight-loss drug: Lawsuit
Amid ongoing legal battles over coveted GLP-1 therapies, a drug vendor in Washington state is accused of running an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Novo Nordisk
Wegovy
United States
Eli Lilly and Company
Feedback